Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis.
暂无分享,去创建一个
W. Xiao | Yang Sun | Lingdong Kong | Hai-Bo Li | Jiao Qu | Tao Zhang | Minyi Zhang | Chenglin Song | Hai-bo Li | Yanpin Gu | Songjun Liu | W-F Lv
[1] Ying Zhu,et al. Guizhi Fuling Wan reduces autophagy of granulosa cell in Rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. , 2021, Journal of ethnopharmacology.
[2] Yanling Xiao,et al. Guizhi Fuling wan for chronic pelvic inflammatory disease protocol , 2020, Medicine.
[3] Ying Zhu,et al. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis , 2020, Frontiers in Endocrinology.
[4] Xiaohua Song,et al. Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases , 2020, Frontiers in Neuroscience.
[5] H. Taylor,et al. Endometriosis: The Role of Iron Overload and Ferroptosis , 2020, Reproductive Sciences.
[6] Bei Sun,et al. Ferroptosis: past, present and future , 2020, Cell Death & Disease.
[7] I. Shih,et al. The Origin and Pathogenesis of Endometriosis. , 2020, Annual review of pathology.
[8] S. Salvador,et al. Guideline No. 392-Classification and Management of Endometrial Hyperplasia. , 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[9] L. Insabato,et al. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta‐analysis , 2019, Acta obstetricia et gynecologica Scandinavica.
[10] Antonio Cuadrado,et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases , 2019, Nature Reviews Drug Discovery.
[11] B. Stockwell,et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.
[12] Liuting Zeng,et al. A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids , 2017, Experimental and therapeutic medicine.
[13] M. Rauh,et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis , 2017, Oncogenesis.
[14] Hongchuan Jin,et al. Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia , 2017, Theranostics.
[15] M. Arends,et al. New concepts for an old problem: the diagnosis of endometrial hyperplasia , 2016, Human reproduction update.
[16] W. Xiao,et al. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction. , 2016, Journal of ethnopharmacology.
[17] Zhenzhong Wang,et al. Integrated identification, qualification and quantification strategy for pharmacokinetic profile study of Guizhi Fuling capsule in healthy volunteers , 2016, Scientific Reports.
[18] H. Hsieh,et al. Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model , 2016, Molecular medicine.
[19] A. Dwivedi,et al. Therapeutic options for management of endometrial hyperplasia , 2015, Journal of gynecologic oncology.
[20] Donna D. Zhang,et al. p62 links autophagy and Nrf2 signaling. , 2015, Free radical biology & medicine.
[21] H. Inoue,et al. Activation of Nrf2/Keap1 signaling and autophagy induction against oxidative stress in heart in iron deficiency , 2015, Bioscience, biotechnology, and biochemistry.
[22] M. K. Kim,et al. Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method? , 2014, Journal of gynecologic oncology.
[23] K. Terasawa,et al. Identification of a Predictive Biomarker for the Beneficial Effect of Keishibukuryogan, a Kampo (Japanese Traditional) Medicine, on Patients with Climacteric Syndrome , 2014, Evidence-based complementary and alternative medicine : eCAM.
[24] W. Hurd,et al. Diagnosis and management of endometrial hyperplasia. , 2012, Journal of minimally invasive gynecology.
[25] M. R. Lamprecht,et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.
[26] Rochelle L. Garcia,et al. Complex Hyperplasia With and Without Atypia: Clinical Outcomes and Implications of Progestin Therapy , 2010, Obstetrics and gynecology.
[27] F. Demirkıran,et al. The effect of long‐term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[28] Mark Hannink,et al. Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.
[29] Young-Chae Chang,et al. Effects of the Geiji‐Bokryung‐Hwan on Carrageenan‐Induced Inflammation in Mice and Cyclooxygenase‐2 in Hepatoma Cells of HepG2 and Hep3B , 2004, Immunopharmacology and immunotoxicology.
[30] R. Kurman,et al. The behavior of endometrial hyperplasia. A long‐term study of “untreated” hyperplasia in 170 patients , 1985 .